Patents by Inventor Anna K. Bassil

Anna K. Bassil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment
    Patent number: 9446041
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: September 20, 2016
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha
  • METHOD OF TREATMENT
    Publication number: 20160074394
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 30, 2015
    Publication date: March 17, 2016
    Inventors: Anna K. BASSIL, Soren BEINKE, Rabinder Kumar PRINJHA
  • Method of treatment
    Patent number: 9242962
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: January 26, 2016
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha
  • METHOD OF TREATMENT
    Publication number: 20140256739
    Abstract: The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 2, 2012
    Publication date: September 11, 2014
    Inventors: Anna K. Bassil, Soren Beinke, Rabinder Kumar Prinjha